These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32951583)

  • 1. Anti-Cancer Activity of Curcumin on Multiple Myeloma.
    Mirzaei H; Bagheri H; Ghasemi F; Khoi JM; Pourhanifeh MH; Heyden YV; Mortezapour E; Nikdasti A; Jeandet P; Khan H; Sahebkar A
    Anticancer Agents Med Chem; 2021; 21(5):575-586. PubMed ID: 32951583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of curcumin as an effective adjuvant to cancer therapy: A short review.
    Bashang H; Tamma S
    Biotechnol Appl Biochem; 2020 Mar; 67(2):171-179. PubMed ID: 31608504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terpecurcumins A-I from the rhizomes of Curcuma longa: absolute configuration and cytotoxic activity.
    Lin X; Ji S; Li R; Dong Y; Qiao X; Hu H; Yang W; Guo D; Tu P; Ye M
    J Nat Prod; 2012 Dec; 75(12):2121-31. PubMed ID: 23153397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa.
    Yue GG; Chan BC; Hon PM; Lee MY; Fung KP; Leung PC; Lau CB
    Food Chem Toxicol; 2010; 48(8-9):2011-20. PubMed ID: 20438793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive chemical constituents of Curcuma longa L. rhizomes extract inhibit the growth of human hepatoma cell line (HepG2).
    Abdel-Lateef E; Mahmoud F; Hammam O; El-Ahwany E; El-Wakil E; Kandil S; Abu Taleb H; El-Sayed M; Hassenein H
    Acta Pharm; 2016 Sep; 66(3):387-98. PubMed ID: 27383887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: comparison with curcumin.
    Tyagi AK; Prasad S; Yuan W; Li S; Aggarwal BB
    Invest New Drugs; 2015 Dec; 33(6):1175-86. PubMed ID: 26521943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin's Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions.
    Zhai K; Brockmüller A; Kubatka P; Shakibaei M; Büsselberg D
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33105719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of antitumor constituents in curcuminoids from Curcuma longa L. based on the composition-activity relationship.
    Jiang JL; Jin XL; Zhang H; Su X; Qiao B; Yuan YJ
    J Pharm Biomed Anal; 2012 Nov; 70():664-70. PubMed ID: 22682511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin: a promising agent targeting cancer stem cells.
    Zang S; Liu T; Shi J; Qiao L
    Anticancer Agents Med Chem; 2014; 14(6):787-92. PubMed ID: 24851881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
    Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
    Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in study of genus Curcuma].
    Ge YW; Gao HM; Wang ZM
    Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2461-7. PubMed ID: 18330232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin in combined cancer therapy.
    Troselj KG; Kujundzic RN
    Curr Pharm Des; 2014; 20(42):6682-96. PubMed ID: 25341940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect and Mechanism of Curcumin on EZH2 - miR-101 Regulatory Feedback Loop in Multiple Myeloma.
    Wu C; Ruan T; Liu W; Zhu X; Pan J; Lu W; Yan C; Tao K; Zhang W; Zhang C
    Curr Pharm Des; 2018; 24(5):564-575. PubMed ID: 28322158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density functional theory calculations in stereochemical determination of terpecurcumins J-W, cytotoxic terpene-conjugated curcuminoids from Curcuma longa L.
    Lin X; Ji S; Qiao X; Hu H; Chen N; Dong Y; Huang Y; Guo D; Tu P; Ye M
    J Org Chem; 2013 Dec; 78(23):11835-48. PubMed ID: 24219305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin augments the cytostatic and anti-invasive effects of mitoxantrone on carcinosarcoma cells in vitro.
    Luty M; Kwiecień E; Firlej M; Łabędź-Masłowska A; Paw M; Madeja Z; Czyż J
    Acta Biochim Pol; 2016; 63(3):397-401. PubMed ID: 27390785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin Therapeutic Modulation of the Wnt Signaling Pathway.
    Ashrafizadeh M; Ahmadi Z; Mohamamdinejad R; Yaribeygi H; Serban MC; Orafai HM; Sahebkar A
    Curr Pharm Biotechnol; 2020; 21(11):1006-1015. PubMed ID: 32133961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways.
    Allegra A; Speciale A; Molonia MS; Guglielmo L; Musolino C; Ferlazzo G; Costa G; Saija A; Cimino F
    Toxicol In Vitro; 2018 Mar; 47():186-194. PubMed ID: 29223572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological researches of curcumin solid dispersions in treatment of cancer].
    Mei XT; Xu DH; He XN; Lu YC
    Zhong Yao Cai; 2012 Oct; 35(10):1645-9. PubMed ID: 23627135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity and Apoptosis Effects of Curcumin Analogue (2E,6E)-2,6-Bis(2,3-Dimethoxybenzylidine) Cyclohexanone (DMCH) on Human Colon Cancer Cells HT29 and SW620 In Vitro.
    Rahim NFC; Hussin Y; Aziz MNM; Mohamad NE; Yeap SK; Masarudin MJ; Abdullah R; Akhtar MN; Alitheen NB
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33652694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma.
    Luthra PM; Lal N
    Eur J Med Chem; 2016 Feb; 109():23-35. PubMed ID: 26748069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.